vs

Side-by-side financial comparison of GRAIL, Inc. (GRAL) and LandBridge Co LLC (LB). Click either name above to swap in a different company.

LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $43.6M, roughly 1.3× GRAIL, Inc.). LandBridge Co LLC runs the higher net margin — 14.2% vs -227.5%, a 241.7% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs 14.0%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-63.9M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 27.7%).

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

GRAL vs LB — Head-to-Head

Bigger by revenue
LB
LB
1.3× larger
LB
$56.8M
$43.6M
GRAL
Growing faster (revenue YoY)
LB
LB
+41.6% gap
LB
55.6%
14.0%
GRAL
Higher net margin
LB
LB
241.7% more per $
LB
14.2%
-227.5%
GRAL
More free cash flow
LB
LB
$185.9M more FCF
LB
$122.0M
$-63.9M
GRAL
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
27.7%
GRAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRAL
GRAL
LB
LB
Revenue
$43.6M
$56.8M
Net Profit
$-99.2M
$8.1M
Gross Margin
Operating Margin
-285.4%
60.0%
Net Margin
-227.5%
14.2%
Revenue YoY
14.0%
55.6%
Net Profit YoY
-2.2%
-83.7%
EPS (diluted)
$-2.37
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRAL
GRAL
LB
LB
Q4 25
$43.6M
$56.8M
Q3 25
$36.2M
$50.8M
Q2 25
$35.5M
$47.5M
Q1 25
$31.8M
$44.0M
Q4 24
$38.3M
$36.5M
Q3 24
$28.7M
$28.5M
Q2 24
$32.0M
$26.0M
Q1 24
$26.7M
$19.0M
Net Profit
GRAL
GRAL
LB
LB
Q4 25
$-99.2M
$8.1M
Q3 25
$-89.0M
$8.1M
Q2 25
$-114.0M
$7.5M
Q1 25
$-106.2M
$6.5M
Q4 24
$-97.1M
$49.3M
Q3 24
$-125.7M
$2.7M
Q2 24
$-1.6B
$-57.7M
Q1 24
$-218.9M
$10.8M
Operating Margin
GRAL
GRAL
LB
LB
Q4 25
-285.4%
60.0%
Q3 25
-346.2%
60.8%
Q2 25
-446.9%
60.0%
Q1 25
-482.5%
57.0%
Q4 24
-358.0%
49.4%
Q3 24
-640.5%
11.2%
Q2 24
-5133.8%
-197.4%
Q1 24
-851.1%
71.1%
Net Margin
GRAL
GRAL
LB
LB
Q4 25
-227.5%
14.2%
Q3 25
-245.8%
15.9%
Q2 25
-320.7%
15.8%
Q1 25
-333.6%
14.7%
Q4 24
-253.8%
135.2%
Q3 24
-438.7%
9.3%
Q2 24
-4958.8%
-222.1%
Q1 24
-819.3%
56.7%
EPS (diluted)
GRAL
GRAL
LB
LB
Q4 25
$-2.37
$0.24
Q3 25
$-2.46
$0.26
Q2 25
$-3.18
$0.24
Q1 25
$-3.10
$0.20
Q4 24
$-1.49
Q3 24
$-3.94
$-0.04
Q2 24
$-51.06
Q1 24
$-7.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRAL
GRAL
LB
LB
Cash + ST InvestmentsLiquidity on hand
$249.7M
$30.7M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$2.6B
$340.3M
Total Assets
$2.9B
$1.4B
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRAL
GRAL
LB
LB
Q4 25
$249.7M
$30.7M
Q3 25
$126.9M
$28.3M
Q2 25
$127.4M
$20.3M
Q1 25
$133.9M
$14.9M
Q4 24
$214.2M
$37.0M
Q3 24
$853.6M
$14.4M
Q2 24
$958.8M
$24.6M
Q1 24
$199.7M
Total Debt
GRAL
GRAL
LB
LB
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
GRAL
GRAL
LB
LB
Q4 25
$2.6B
$340.3M
Q3 25
$2.2B
$272.0M
Q2 25
$2.3B
$266.4M
Q1 25
$2.4B
$217.0M
Q4 24
$2.5B
$211.8M
Q3 24
$2.6B
$97.2M
Q2 24
$2.7B
$296.4M
Q1 24
$162.3M
Total Assets
GRAL
GRAL
LB
LB
Q4 25
$2.9B
$1.4B
Q3 25
$2.6B
$1.1B
Q2 25
$2.7B
$1.1B
Q1 25
$2.8B
$1.0B
Q4 24
$3.0B
$1.0B
Q3 24
$3.1B
$689.9M
Q2 24
$3.3B
$710.5M
Q1 24
Debt / Equity
GRAL
GRAL
LB
LB
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRAL
GRAL
LB
LB
Operating Cash FlowLast quarter
$-63.8M
$126.3M
Free Cash FlowOCF − Capex
$-63.9M
$122.0M
FCF MarginFCF / Revenue
-146.5%
214.9%
Capex IntensityCapex / Revenue
0.2%
7.5%
Cash ConversionOCF / Net Profit
15.68×
TTM Free Cash FlowTrailing 4 quarters
$-299.9M
$207.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRAL
GRAL
LB
LB
Q4 25
$-63.8M
$126.3M
Q3 25
$-63.2M
$34.9M
Q2 25
$-77.0M
$37.3M
Q1 25
$-95.0M
$15.9M
Q4 24
$67.6M
Q3 24
$-104.6M
$7.5M
Q2 24
$-171.8M
$16.0M
Q1 24
$-207.3M
$17.2M
Free Cash Flow
GRAL
GRAL
LB
LB
Q4 25
$-63.9M
$122.0M
Q3 25
$-63.6M
$33.7M
Q2 25
$-77.3M
$36.1M
Q1 25
$-95.1M
$15.8M
Q4 24
$66.7M
Q3 24
$-105.6M
$7.1M
Q2 24
$-173.2M
$15.7M
Q1 24
$-209.8M
$17.1M
FCF Margin
GRAL
GRAL
LB
LB
Q4 25
-146.5%
214.9%
Q3 25
-175.8%
66.3%
Q2 25
-217.6%
75.9%
Q1 25
-298.6%
36.0%
Q4 24
182.6%
Q3 24
-368.4%
25.1%
Q2 24
-541.7%
60.4%
Q1 24
-785.3%
90.1%
Capex Intensity
GRAL
GRAL
LB
LB
Q4 25
0.2%
7.5%
Q3 25
1.1%
2.3%
Q2 25
1.0%
2.6%
Q1 25
0.2%
0.2%
Q4 24
2.7%
Q3 24
3.4%
1.1%
Q2 24
4.3%
1.4%
Q1 24
9.5%
0.5%
Cash Conversion
GRAL
GRAL
LB
LB
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
Q2 24
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRAL
GRAL

Screening Revenue$42.3M97%
Developmental Services Revenue$1.3M3%

LB
LB

Segment breakdown not available.

Related Comparisons